Healthcare &Life Sciences

Medical technology businesses often operate through a combination of product supply, software, installation, training, maintenance, financing, distribution and long-term customer support.

The legal framework needs to reflect how those elements interact. Delivery and installation responsibilities, acceptance, title and risk, warranty, service levels, updates, quality responsibilities, regulatory cooperation, field actions, data and termination can all affect the commercial relationship.

Our experience with sophisticated medical-technology and equipment arrangements informs a practical approach to these interfaces. We support manufacturers, suppliers, distributors, healthcare organisations and other stakeholders on the commercial and contractual workstreams while coordinating specialist product-regulatory or technical advice where required.

Digital health can combine clinical workflows, software, cloud infrastructure, connected devices, algorithms, data processing and managed services. The legal analysis therefore needs to consider the technology and the healthcare environment together.

We advise on commercial contracting, software and cloud arrangements, data-processing terms, cybersecurity provisions, implementation, integration, service levels, support, change, business continuity and exit.

Where a solution may be subject to medical-device, clinical, AI or other specialist regulation, the applicable classification and regulatory requirements should be determined with appropriately qualified regulatory or technical advisers.

Hospitals, clinics, diagnostic organisations and other healthcare providers increasingly depend on complex networks of equipment suppliers, technology providers, service partners, financiers and data processors.

We support healthcare organisations and their counterparties on procurement, commercial agreements, technology and digital services, equipment arrangements, strategic partnerships, outsourcing, data and privacy, financing interfaces and dispute-risk management.

For public-sector healthcare arrangements, procurement, statutory authority and public-law requirements should be assessed for the particular institution and transaction.

Healthcare businesses frequently depend on distributors, resellers, agents, service partners and strategic collaborators to reach customers and support products across different markets.

We advise on route-to-market structures, appointment and territory, exclusivity, performance, pricing interfaces, compliance, product responsibilities, regulatory cooperation, audit, data, service obligations, termination and transition.

Because third parties can create significant anti-bribery, regulatory and reputational exposure in healthcare, commercial arrangements should be aligned with proportionate due diligence, approval, monitoring and contractual compliance controls.

Healthcare organisations often require flexible structures to acquire equipment, technology and services while managing capital constraints and payment cycles.

Working with our Banking, Finance & Capital practice, we support equipment finance, leasing, receivables and other structured commercial-finance arrangements connected with healthcare transactions.

We pay particular attention to the relationship between the financing documents and the underlying sale, supply, delivery, installation, acceptance, warranty and service obligations so that the legal structures operate coherently.

Healthcare and life-sciences businesses may operate within product, facility, professional, quality, safety, procurement, advertising, data and business-conduct regimes.

In Nigeria, the National Agency for Food and Drug Administration and Control is a principal regulator for regulated products including medical devices and other healthcare products within its statutory remit. Other authorities and professional or sector regulators may also be relevant depending on the product, service, facility and activity.

Paraphoenix supports the legal and commercial dimensions of regulated healthcare arrangements, including contractual allocation of regulatory responsibilities, compliance frameworks, third-party controls, anti-bribery and corruption, investigations, data and cybersecurity.

We do not substitute for specialist scientific, clinical, quality-system or product-registration advisers. Regulatory requirements should be confirmed for the particular product, activity and current legal framework.

Healthcare data can be highly sensitive, and digital healthcare systems may support business-critical or patient-facing operations. Contractual arrangements therefore need to address privacy, security, access, data use, incident management, resilience, continuity and supplier responsibility.

Working with our Technology, Data & Digital practice, we advise on data-processing terms, cloud and software arrangements, cybersecurity obligations, incident provisions, audit, subcontracting, service continuity and transition.

Nigeria's data-protection framework, including the Nigeria Data Protection Act 2023 and current regulatory guidance, should be considered alongside any healthcare-specific requirements applicable to the relevant processing activity.

Healthcare investment may involve acquisitions, joint ventures, strategic alliances, greenfield operations, technology partnerships, distribution platforms, healthcare infrastructure or financing structures.

We support investors, businesses and other stakeholders on corporate structuring, due diligence, transaction documentation, commercial contracts, regulatory and compliance interfaces, financing and implementation.

For cross-border healthcare transactions, we can coordinate Nigerian-law advice with carefully selected independent local counsel and professional advisers in other jurisdictions.